Minish Jain
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 38
- HER2/EGFR in Cancer Research 15
- Cancer Treatment and Pharmacology 12
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Sudeep GuptaAjay MehtaRajnish NagarkarSubhashini JohnRobert G. PetitPartha BasuShailesh BondardeVirginia Kaklamani
- Journals
- Journal of Clinical Oncology (22 papers)Blood (7 papers)Cancer Research (4 papers)European Journal of Cancer (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Minish Jain
56 papers receiving 805 citations
Peers
Comparison fields: 5 of 73
- Oncology 459
- Immunology 275
- Biotechnology 70
- Hematology 61
- Obstetrics and Gynecology 42
Countries citing papers authored by Minish Jain
This map shows the geographic impact of Minish Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minish Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minish Jain more than expected).
Fields of papers citing papers by Minish Jain
This network shows the impact of papers produced by Minish Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minish Jain. The network helps show where Minish Jain may publish in the future.
Co-authors
The 25 scholars most cited alongside Minish Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 9 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 1 | |
| 15 | 2019 | 3 | |
| 16 | 2019 | 4 | |
| 17 | 2015 | 199 | |
| 18 | 2014 | 37 | |
| 19 | 2014 | 62 | |
| 20 | 2011 | 7 |
About Minish Jain
Minish Jain is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Biotechnology, having authored 68 papers that have together received 828 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (15 papers), Prostate Cancer Treatment and Research (13 papers), Cancer Treatment and Pharmacology (12 papers), Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Oncology (459 citations), Immunology (275 citations), Biotechnology (70 citations), Hematology (61 citations) and Obstetrics and Gynecology (42 citations). Minish Jain has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Sudeep Gupta, Ajay Mehta, Rajnish Nagarkar, Subhashini John, Robert G. Petit, Partha Basu, Shailesh Bondarde, Virginia Kaklamani, Quincy S. Chu and Rodryg Ramlau. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.